Published Date: 08 Mar 2023
Roche's Genentech Inc sued Biogen MA Inc in federal court in San Francisco, alleging that Biogen owed additional patent royalties from worldwide sales of its blockbuster multiple sclerosis and Crohn's disease drug, Tysabri.
Read Full News1.
How access to specialized cancer centers affects glioblastoma outcomes
2.
How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs
3.
Nasal therapeutic HPV vaccine could prevent cervical cancer
4.
Atezolizumab + Cabozantinib Postpones mCRPC Progression.
5.
Report suggests a big improvement in lung cancer survival
1.
Clonal Hematopoiesis Dynamics and Future Hematologic Outcomes
2.
Tumor Ecosystem Rewiring Through Adaptive Therapeutics
3.
Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology
4.
Tumor Microenvironment Reprogramming for Regenerative Cancer Recovery
5.
Unlocking the Mystery of Ovarian Cancer Staging
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
2.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
3.
Navigating the Complexities of Ph Negative ALL - Part II
4.
How Blood Tests Help Detect Hematological Disorders
5.
Navigating the Complexities of Ph Negative ALL - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation